Atomoxetine once daily for 24 weeks in adults with attention-deficit/ hyperactivity disorder (ADHD): Impact of treatment on family functioning

Linda Wietecha, Joel Young, Dustin Ruff, David Dunn, Robert L. Findling, Keith Saylor

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Atomoxetine once daily for 24 weeks in adults with attention-deficit/ hyperactivity disorder (ADHD): Impact of treatment on family functioning'. Together they form a unique fingerprint.

Medicine & Life Sciences